AbbVie
ABBV
#33
Rank
C$496.54 B
Marketcap
C$280.73
Share price
-2.23%
Change (1 day)
5.96%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2025 (TTM): C$9.15 Billion

According to AbbVie's latest financial reports the company's current earnings are C$61.16 Billion. , an increase over its 2024 earnings that were of C$5.04 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2025

Annual earnings

Year Earnings Change
2025 C$8.96 B77.53%
2024 C$5.04 B-40.54%
2023 C$8.49 B-53.62%
2022 C$18.31 B3.76%
2021 C$17.64 B282.25%
2020 C$4.61 B-59.67%
2019 C$11.44 B62.13%
2018 C$7.06 B-32.74%
2017 C$10.49 B-1.99%
2016 C$10.71 B18.65%
2015 C$9.02 B180.5%
2014 C$3.21 B-55.57%
2013 C$7.24 B-6.86%
2012 C$7.77 B56.05%
2011 C$4.98 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
C$13.84 B 54.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$34.96 B 290.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$12.19 B 36.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$2.11 B-76.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.31 B 48.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$12.67 B 41.40%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
C$19.16 B 113.85%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
C$13.44 B 50.00%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
C$0.86 B-90.35%๐Ÿ‡บ๐Ÿ‡ธ USA